Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02310126 · ClinicalTrials.gov registry record · NA
Handling Comparison Between Two Contact Lens Types
A NA study of Presbyopia, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
- 8
- Study locations
NCT02310126: Completed NA study of Presbyopia, sponsored by Johnson & Johnson Vision Care.
NCT02310126 is a NA study of Presbyopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 195 participants, below the 265-participant average among 38 other Presbyopia trials with a reported enrollment target (26% lower). The trial reports 8 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02310126, a NA study of Presbyopia, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
- 8
- Study locations
Study Summary
Subjects will evaluate each study lens in a random order. The lenses will be worn in both eyes for a short period.
Primary Outcome
CLUE Overall Lens Handling is assessed using the Contact Lens User Experience (CLUE)TM questionnaire. CLUE is a validated patient-reported outcomes questionnaire to assess patient experience attributes of soft, disposable contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response. 97% of the s
Conditions Studied
Interventions
- DEVICE etafilcon A (multi-focal)
- DEVICE etafilcon A (sphere)
Study Locations (8)
Florida
- Baymeadows Vision Center - Jacksonville
- Eye Elements Eyecare - Jacksonville
- Vistakon Research Clinic - Jacksonville
- Golden Family Eyecare - Sarasota
- Eye Associates of Winter Park - Winter Park
Tennessee
- Optometry Group LLC - Memphis
- Nashville Vision Associates - Nashville
Ohio
- Central Ohio Eyecare - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2014-11-01 |
| Est. Completion | 2014-12-01 |
| Phase | NA |
What the finished NCT02310126 record still lists
NCT02310126 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 265-participant average among 38 other Presbyopia trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which etafilcon A (multi-focal) is the first listed.
NCT02310126 lists 8 locations in 3 states (Florida, Tennessee, Ohio).
Frequently Asked Questions
What is clinical trial NCT02310126 about?
NCT02310126 is a clinical study titled "Handling Comparison Between Two Contact Lens Types". Subjects will evaluate each study lens in a random order. The lenses will be worn in both eyes for a short period.
What is the current status of trial NCT02310126?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2014-11-01. Estimated completion is 2014-12-01.
What conditions does trial NCT02310126 study?
This clinical trial studies the following conditions: Presbyopia.
What interventions are being tested in trial NCT02310126?
The interventions under investigation include: etafilcon A (multi-focal) (DEVICE), etafilcon A (sphere) (DEVICE).
Who is sponsoring clinical trial NCT02310126?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02310126 being conducted?
This trial has 8 study locations across Florida, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02310126's enrollment target sits among peer trials
195 9th of 38 higher than 30 of 38 other Presbyopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Presbyopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI